PacBio Named Senior Party in USPTO Interference Involving VisiGen Patent

PacBio and Life Technologies, which owns VisiGen, are developing potentially rivaling real-time, single-molecule sequencing platforms, and the interference shows they claim ownership to related IP.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.